Company intelligence / Profile preview

Sinopharm Weiqida Pharmaceutical

Datong, Shanxi, Chinapharmasource.global ↗

Ownership: Private
Development stage: Other

Overview

Sinopharm Weiqida Pharmaceutical operates as a major manufacturer of active pharmaceutical ingredients (APIs) and finished formulations, with commercialized products in antibiotics such as cephalosporins and penicillins, as well as diabetes drugs like acarbose. The company has established strategic partnerships to ensure stable supply chains for key products such as acarbose API, supporting large-scale commercialization in China’s national drug procurement programs. Over half of its sales are from international markets.

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: Small moleculeBiologic (via fermentation for APIs)
Industry: Biotech

Drug pipeline

1 asset

Weiqida

Unknown

Partnerships

Uni-Bio Science Group Limited, Suzhou Yingli Medical Technology Co., Ltd. – strategic partnership on the acarbose value chain for diabetes treatment.

Beyond the preview

Go deeper on Sinopharm Weiqida Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinopharm Weiqida Pharmaceutical.

Explore the full profile